3.81.57.77
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Oncology

Positive outcomes possible for patients who stop immune checkpoint inhibitor treatment

Patients with cancer who stop receiving PD-1/PD-L1 immune checkpoint inhibitor (ICI) treatment after achieving sustained disease control (SDC) can still experience positive outcomes, according to a retrospective study. The study, which analyzed electronic health records of 204 cancer patients treated with ICI between 2014 and 2021, found that 44 patients...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-